ClinConnect ClinConnect Logo
Search / Trial NCT05653570

Electrical Stimulation for Erector Spinae Plane Catheter Insertion

Launched by STANFORD UNIVERSITY · Dec 8, 2022

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Erector Spinae Plane Electrical Stimulation

ClinConnect Summary

This clinical trial is exploring a new method to help manage pain after shoulder surgery, specifically looking at a technique called the erector spinae plane (ESP) block. The researchers want to see if using electrical stimulation (a technique that helps find the best spot for the catheter) along with ultrasound guidance can improve the placement of the ESP catheter, which delivers pain relief medication. This study aims to enhance the effectiveness of pain control after surgery and to understand how often patients might experience certain nerve-related sensations during the procedure.

To participate in this trial, individuals must be scheduled for elective total or total reverse shoulder arthroplasty, which is a type of shoulder surgery. However, people who have a history of using opioids, those undergoing emergency procedures, or individuals with certain medical devices like pacemakers will not be eligible. If you join the study, you can expect to receive careful monitoring during the catheter placement procedure, and the researchers will track your pain levels afterwards to see how well the method works. This trial is a great opportunity to contribute to improving pain management techniques for future shoulder surgery patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • elective total or total reverse shoulder arthroplasty
  • Exclusion Criteria:
  • inability to provide consent
  • history of active opioid use
  • emergency procedures
  • shoulder arthroscopy
  • partial shoulder replacement
  • shoulder resurfacing
  • any revision shoulder surgery
  • any indwelling deep brain stimulator, pacemaker, and/or other neurostimulators

About Stanford University

Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.

Locations

Patients applied

0 patients applied

Trial Officials

Jan Boublik, MD

Principal Investigator

Stanford University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials